MARK1 and thyroid gland carcinoma: In the BrafV600E murine thyroid cancer, β-catenin expression is up-regulated and its knockout results in down-regulation of MARK signaling pathway, indicating a positive crosstalk between MAPK and Wnt/β-catenin signaling pathways.